jianbing zhang | PARTNER | suzhou

Former Partner at IDG Capital; board member of multiple publicly listed and leading biomedical companies; with over 20 years of hands-on experience spanning pharmaceutical R&D, drug marketing and sales, and investment. During his tenure as Partner at IDG Capital, Jianbing led investments in over 80 companies, achieving more than 20 successful IPOs, and has been repeatedly recognized as one of China's top healthcare investors.

  • •HEC Pharm (leading the $1 B equity investment)

    •Kelun-Biotech (The largest ADC oncology biotech platform in China)

    •MGI Tech (The largest gene sequencing instrument company in Asia)

    •Ping An Good Doctor (The largest mobile internet healthcare platform in China)

    •Shanghai Model Organisms (A leading player in China's model animal sector), etc.

  • •Fund Practitioner Qualification Certificate

    •Shenzhen Stock Exchange Independent Director Qualification Certificate

    •National Licensed Pharmacist Qualification Certificate

    •B.S. in Biochemistry, Nanjing Tech University

    •M.B.A., Cheung Kong Graduate School of Business (CKGSB)